Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study Evaluating the Efficacy and Safety of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in Patients Undergoing Bronchoscopy

NCT02296892 is registered in ClinicalTrials.gov with Paion UK Ltd. as lead sponsor.

NCT NCT02296892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02296892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study Evaluating the Efficacy and Safety of Remimazolam (CNS 7056) Compared to Placebo and Midazolam in Patients Undergoing Bronchoscopy
Lead sponsor
Paion UK Ltd.
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2015
Completion date
March 13, 2017
Enrollment
446 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

bronchoscopy